These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 15262836)

  • 21. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism.
    Hirsh J; Siragusa S; Cosmi B; Ginsberg JS
    Thromb Haemost; 1995 Jul; 74(1):360-3. PubMed ID: 8578485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
    Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; van den Berg-Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
    N Engl J Med; 2003 Oct; 349(18):1695-702. PubMed ID: 14585937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.
    Califf RM; Petersen JL; Hasselblad V; Mahaffey KW; Ferguson JJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S91-9. PubMed ID: 16124953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
    Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolysis for pulmonary embolism.
    Porter RS; Dipalma JR
    Am Fam Physician; 1991 Oct; 44(4):1365-70. PubMed ID: 1927847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: a meta-analysis.
    Riera-Mestre A; Becattini C; Giustozzi M; Agnelli G
    Thromb Res; 2014 Dec; 134(6):1265-71. PubMed ID: 25457585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of thrombolytic therapy in the treatment of pulmonary embolism.
    Pini M
    Haematologica; 1997; 82(3):258-61. PubMed ID: 9234569
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombolytic therapy for the treatment of acute pulmonary embolism.
    Anderson DR; Levine MN
    CMAJ; 1992 Apr; 146(8):1317-24. PubMed ID: 1555162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
    Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.
    Agnelli G; Becattini C; Kirschstein T
    Arch Intern Med; 2002 Dec 9-23; 162(22):2537-41. PubMed ID: 12456225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolytic therapy in pulmonary embolism.
    Goldhaber SZ; Bounameaux H
    Semin Vasc Med; 2001 Nov; 1(2):213-20. PubMed ID: 15199505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is thrombolytic therapy effective for pulmonary embolism?
    Almoosa K
    Am Fam Physician; 2002 Mar; 65(6):1097-102. PubMed ID: 11925086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute pulmonary embolism. Aggressive therapy with anticoagulants and thrombolytics.
    Handler JA; Feied CF
    Postgrad Med; 1995 Jan; 97(1):61-2, 65-8, 71-2. PubMed ID: 7816717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolytic therapy for pulmonary embolism.
    Hao Q; Dong BR; Yue J; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2015 Sep; (9):CD004437. PubMed ID: 26419832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.
    Simonneau G; Sors H; Charbonnier B; Page Y; Laaban JP; Azarian R; Laurent M; Hirsch JL; Ferrari E; Bosson JL; Mottier D; Beau B
    N Engl J Med; 1997 Sep; 337(10):663-9. PubMed ID: 9278462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.